Andrew C. Li
Nature · with Glass · 2000–2005
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Andrew C. Li trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Andrew C. Li overall
Papers from Andrew C. Li's perspective
Ordered by how strongly the researchers Andrew C. Li trusts endorse each paper. Same corpus, a different order for every researcher.
- Toll-like receptors: critical proteins linking innate and acquired immunity (Nature Immunology)
- Generation of C-reactive protein and complement components in atherosclerotic plaques. (American Journal of Pathology)
- Synthetic LXR ligand inhibits the development of atherosclerosis in mice (Proceedings of the National Academy of Sciences of the United States of America)
- Phagocytes and oxidative stress. (American Journal of Medicine)
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. (Journal of Clinical Investigation)
- Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. (Journal of Clinical Investigation)
- Role of LXRs in control of lipogenesis. (Genes & Development)
- Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. (Science)
- Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. (Journal of Biological Chemistry)
- Toll-like receptors and innate immunity (Journal of molecular medicine)
Their papers
- Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice (2000) — 807 citations
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ (2005) — 1,315 citations
- The macrophage foam cell as a target for therapeutic intervention (2002) — 718 citations